Tenet Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	2,651	2,367	4,064	1,311	1,001	1,476
Depreciation & Amortization	886	863	818	870	841	855
Stock-Based Compensation	108	104	67	66	56	56
Other Adjustments	218.5	187	-2,885	210	542	71
Change in Receivables	61	20	245	-29	-140	-197
Changes in Inventories	442	-73	-86	-139	-64	-52
Changes in Accounts Payable	40	209	-30	215	-898	-584
Changes in Income Taxes Payable	102	-25	16	10	-26	68
Changes in Other Operating Activities	-125	-112	-162	-140	-229	-125
Operating Cash Flow	4,366	3,540	2,047	2,374	1,083	1,568
Operating Cash Flow Growth	91.83%	72.94%	-13.77%	119.21%	-30.93%	-53.98%
Capital Expenditures	-1,017	-1,010	-931	-751	-762	-658
Sale of Property, Plant & Equipment	29	38	4,981	71	210	1,248
Purchases of Investments	-99	-90	-94	-104	-92	-108
Proceeds from Sale of Investments	101	93	63	50	76	31
Payments for Business Acquisitions	-402	-308	-571	-224	-234	-1,220
Other Investing Activities	-17	2	-19	-11	-6	-7
Investing Cash Flow	-1,405	-1,275	3,429	-969	-808	-714
Long-Term Debt Issued	2,289	2,276	23	1,370	2,023	2,872
Long-Term Debt Repaid	-2,373	-2,372	-2,243	-1,542	-2,851	-3,221
Net Long-Term Debt Issued (Repaid)	-84	-96	-2,220	-172	-828	-349
Repurchase of Common Stock	-1,356	-1,386	-672	-200	-250	-
Net Common Stock Issued (Repurchased)	-1,356	-1,386	-672	-200	-250	-
Other Financing Activities	-1,384	-919	-793	-663	-703	-587
Financing Cash Flow	-2,993	-2,401	-3,685	-1,035	-1,781	-936
Net Cash Flow	-32	-136	1,791	370	-1,506	-82
Free Cash Flow	3,349	2,530	1,116	1,623	321	910
Free Cash Flow Growth	32.37%	126.70%	-31.24%	405.61%	-64.72%	-68.26%
FCF Margin	15.61%	11.87%	5.40%	7.89%	1.66%	4.62%
Free Cash Flow Per Share	37.64	27.85	11.40	15.49	2.90	8.38
Levered Free Cash Flow	1,947	1,163	605	504	-1,555	69
Unlevered Free Cash Flow	3,343	2,594	4,036	1,915	437.55	1,579

SEC Filings: 10-K · 10-Q